285 related articles for article (PubMed ID: 16329998)
1. Use of constraint-based modeling for the prediction and validation of antimicrobial targets.
Trawick JD; Schilling CH
Biochem Pharmacol; 2006 Mar; 71(7):1026-35. PubMed ID: 16329998
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Use of genomics to select antibacterial targets.
Pucci MJ
Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
[TBL] [Abstract][Full Text] [Related]
4. Crystallizing new approaches for antimicrobial drug discovery.
Schmid MB
Biochem Pharmacol; 2006 Mar; 71(7):1048-56. PubMed ID: 16458857
[TBL] [Abstract][Full Text] [Related]
5. Structure-based approaches to antibiotic drug discovery.
Nicola G; Abagyan R
Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
[TBL] [Abstract][Full Text] [Related]
6. Novel targets for the future development of antibacterial agents.
McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
[TBL] [Abstract][Full Text] [Related]
7. Exploiting current understanding of antibiotic action for discovery of new drugs.
Chopra I; Hesse L; O'Neill AJ
Symp Ser Soc Appl Microbiol; 2002; (31):4S-15S. PubMed ID: 12481824
[TBL] [Abstract][Full Text] [Related]
8. When will the genomics investment pay off for antibacterial discovery?
Mills SD
Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
[TBL] [Abstract][Full Text] [Related]
9. Use of genome-scale microbial models for metabolic engineering.
Patil KR; Akesson M; Nielsen J
Curr Opin Biotechnol; 2004 Feb; 15(1):64-9. PubMed ID: 15102469
[TBL] [Abstract][Full Text] [Related]
10. Delivering novel targets and antibiotics from genomics.
Payne DJ; Holmes DJ; Rosenberg M
Curr Opin Investig Drugs; 2001 Aug; 2(8):1028-34. PubMed ID: 11892909
[TBL] [Abstract][Full Text] [Related]
11. Applications of system-level models of metabolism for analysis of bacterial physiology and identification of new drug targets.
Navid A
Brief Funct Genomics; 2011 Nov; 10(6):354-64. PubMed ID: 22199377
[TBL] [Abstract][Full Text] [Related]
12. Using genomics to develop novel antibacterial therapeutics.
Nagaraj NS; Singh OV
Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176
[TBL] [Abstract][Full Text] [Related]
13. Novel target sites in bacteria for overcoming antibiotic resistance.
Black MT; Hodgson J
Adv Drug Deliv Rev; 2005 Jul; 57(10):1528-38. PubMed ID: 15949866
[TBL] [Abstract][Full Text] [Related]
14. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?
Vicente M; Hodgson J; Massidda O; Tonjum T; Henriques-Normark B; Ron EZ
FEMS Microbiol Rev; 2006 Nov; 30(6):841-52. PubMed ID: 17064283
[TBL] [Abstract][Full Text] [Related]
15. Emerging bacterial enzyme targets.
Su Z; Honek JF
Curr Opin Investig Drugs; 2007 Feb; 8(2):140-9. PubMed ID: 17328230
[TBL] [Abstract][Full Text] [Related]
16. Microbial genomics and drug discovery: exploring innovative routes of drug discovery in the postgenomic era.
Dougherty TJ; Miller PF
IDrugs; 2006 Jun; 9(6):420-2. PubMed ID: 16752312
[TBL] [Abstract][Full Text] [Related]
17. Functional genomics in antibacterial drug discovery.
Freiberg C; Brötz-Oesterhelt H
Drug Discov Today; 2005 Jul; 10(13):927-35. PubMed ID: 15993812
[TBL] [Abstract][Full Text] [Related]
18. Genomic approaches to antibacterial discovery.
Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
[TBL] [Abstract][Full Text] [Related]
19. Predicting gene essentiality using genome-scale in silico models.
Joyce AR; Palsson BØ
Methods Mol Biol; 2008; 416():433-57. PubMed ID: 18392986
[TBL] [Abstract][Full Text] [Related]
20. The ATCG of drug discovery.
Fernandes PB
Curr Opin Mol Ther; 2000 Dec; 2(6):624-32. PubMed ID: 11249739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]